CRISPR-Cas9 in basic and translational aspects of cancer therapy
Introduction: The discovery of gene editing techniques has opened a new era within the field of biology and enabled scientists to manipulate nucleic acid molecules. CRISPR-Cas9 genome engineering has revolutionized this achievement by successful targeting the DNA molecule and editing its sequence. S...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Tabriz University of Medical Sciences
2024-11-01
|
| Series: | BioImpacts |
| Subjects: | |
| Online Access: | https://bi.tbzmed.ac.ir/PDF/bi-14-30087.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832595598007599104 |
|---|---|
| author | Maryam Samareh Salavatipour Zahra Poursalehi Negin Hosseini Rouzbahani Sohaib Mohammadyar Mohammad Vasei |
| author_facet | Maryam Samareh Salavatipour Zahra Poursalehi Negin Hosseini Rouzbahani Sohaib Mohammadyar Mohammad Vasei |
| author_sort | Maryam Samareh Salavatipour |
| collection | DOAJ |
| description | Introduction: The discovery of gene editing techniques has opened a new era within the field of biology and enabled scientists to manipulate nucleic acid molecules. CRISPR-Cas9 genome engineering has revolutionized this achievement by successful targeting the DNA molecule and editing its sequence. Since genomic changes are the basis of the birth and growth of many tumors, CRISPR-Cas9 method has been successfully applied to identify and manipulate the genes which are involved in initiating and driving some neoplastic processes. Methods: By review of the existing literature on application of CRISPR-Cas9 in cancer, different databases, such as PubMed and Google Scholar, we started data collection for "CRISPR-Cas9", "Genome Editing", "Cancer", "Solid tumors", "Hematologic malignancy" "Immunotherapy", "Diagnosis", "Drug resistance" phrases. Clinicaltrials.gov, a resource that provides access to information on clinical trials, was also searched in this review. Results: We have defined the basics of this technology and then mentioned some clinical and preclinical studies using this technology in the treatment of a variety of solid tumors as well as hematologic neoplasms. Finally, we described the progress made by this technology in boosting immune-mediated cell therapy in oncology, such as CAR-T cells, CAR-NK cells, and CAR-M cells. Conclusion: CRISPR-Cas9 system revolutionized the therapeutic strategies in some solid malignant tumors and leukemia through targeting the key genes involved in the pathogenesis of these cancers. |
| format | Article |
| id | doaj-art-2aa16d8ae1c1468bac2aeb8a32266a83 |
| institution | Kabale University |
| issn | 2228-5652 2228-5660 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | Tabriz University of Medical Sciences |
| record_format | Article |
| series | BioImpacts |
| spelling | doaj-art-2aa16d8ae1c1468bac2aeb8a32266a832025-01-18T10:04:44ZengTabriz University of Medical SciencesBioImpacts2228-56522228-56602024-11-01146300873008710.34172/bi.2024.30087bi-30087CRISPR-Cas9 in basic and translational aspects of cancer therapyMaryam Samareh Salavatipour0Zahra Poursalehi1Negin Hosseini Rouzbahani2Sohaib Mohammadyar3Mohammad Vasei4Department of Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, IranDepartment of Applied Cell Sciences, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, IranDepartment of Medical Immunology, Faculty of Medicine, Aja University of Medical Sciences, Tehran, IranDepartment of Hematology and Laboratory Sciences, Faculty of Allied Medicine, Kerman University of Medical Sciences, Kerman, IranGene Therapy Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, IranIntroduction: The discovery of gene editing techniques has opened a new era within the field of biology and enabled scientists to manipulate nucleic acid molecules. CRISPR-Cas9 genome engineering has revolutionized this achievement by successful targeting the DNA molecule and editing its sequence. Since genomic changes are the basis of the birth and growth of many tumors, CRISPR-Cas9 method has been successfully applied to identify and manipulate the genes which are involved in initiating and driving some neoplastic processes. Methods: By review of the existing literature on application of CRISPR-Cas9 in cancer, different databases, such as PubMed and Google Scholar, we started data collection for "CRISPR-Cas9", "Genome Editing", "Cancer", "Solid tumors", "Hematologic malignancy" "Immunotherapy", "Diagnosis", "Drug resistance" phrases. Clinicaltrials.gov, a resource that provides access to information on clinical trials, was also searched in this review. Results: We have defined the basics of this technology and then mentioned some clinical and preclinical studies using this technology in the treatment of a variety of solid tumors as well as hematologic neoplasms. Finally, we described the progress made by this technology in boosting immune-mediated cell therapy in oncology, such as CAR-T cells, CAR-NK cells, and CAR-M cells. Conclusion: CRISPR-Cas9 system revolutionized the therapeutic strategies in some solid malignant tumors and leukemia through targeting the key genes involved in the pathogenesis of these cancers.https://bi.tbzmed.ac.ir/PDF/bi-14-30087.pdfcrispr-cas9gene editingcancersolid tumorshematologic malignancyimmunotherapydiagnosisdrug resistance |
| spellingShingle | Maryam Samareh Salavatipour Zahra Poursalehi Negin Hosseini Rouzbahani Sohaib Mohammadyar Mohammad Vasei CRISPR-Cas9 in basic and translational aspects of cancer therapy BioImpacts crispr-cas9 gene editing cancer solid tumors hematologic malignancy immunotherapy diagnosis drug resistance |
| title | CRISPR-Cas9 in basic and translational aspects of cancer therapy |
| title_full | CRISPR-Cas9 in basic and translational aspects of cancer therapy |
| title_fullStr | CRISPR-Cas9 in basic and translational aspects of cancer therapy |
| title_full_unstemmed | CRISPR-Cas9 in basic and translational aspects of cancer therapy |
| title_short | CRISPR-Cas9 in basic and translational aspects of cancer therapy |
| title_sort | crispr cas9 in basic and translational aspects of cancer therapy |
| topic | crispr-cas9 gene editing cancer solid tumors hematologic malignancy immunotherapy diagnosis drug resistance |
| url | https://bi.tbzmed.ac.ir/PDF/bi-14-30087.pdf |
| work_keys_str_mv | AT maryamsamarehsalavatipour crisprcas9inbasicandtranslationalaspectsofcancertherapy AT zahrapoursalehi crisprcas9inbasicandtranslationalaspectsofcancertherapy AT neginhosseinirouzbahani crisprcas9inbasicandtranslationalaspectsofcancertherapy AT sohaibmohammadyar crisprcas9inbasicandtranslationalaspectsofcancertherapy AT mohammadvasei crisprcas9inbasicandtranslationalaspectsofcancertherapy |